About Technology Issues FAQ

Links

Empagliflozin reduces the risk of a broad spectrum of heart failure outcomes regardless of heart failure status at baseline

Empagliflozin reduces the risk of a broad spectrum of heart failure outcomes regardless of heart failure status at baseline — Distribution of the number of citations over years.

site/software © exaly; All materials licenced under CC by-SA.